EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Case Report: Pediatric B-cell acute lymphoblastic leukemia presenting with recurrent seizures and persistent peripheral blood blast negativity

Ke Cao, Yan Zhang, Xiaojuan Luo, Xueyan Chen

Frontiers in Pediatrics · 2026-11-12 · 14

DOI: 10.3389/fped.2026.1996188 ↗
AbstractBibliografische Angaben

Abstract

Background Central nervous system-predominant pediatric B-cell acute lymphoblastic leukemia (B-ALL) may present without peripheral blood abnormalities, and corticosteroid exposure can cause false-negative CSF cytomorphology. Case presentation A 5-year-and-7-month-old boy presented with recurrent seizures and cranial nerve deficits. Initial peripheral blood smears and CSF examinations were blast-negative. The interval between symptom onset and definitive diagnosis was 8 months; whether early symptoms were leukemia-attributable remains uncertain. In December 2019, repeated lumbar puncture revealed CSF pleocytosis (89 × 10 6 /L) with suspicious blasts. Bone marrow showed 81.5% blasts; flow cytometry confirmed B-lymphoid phenotype. CSF flow cytometry confirmed CNS3 status. KRAS G12 V (10.2% VAF) was detected. Peripheral blood remained blast-negative throughout. He achieved complete remission (morphological blasts <5%; MRD <0.01%) on the CCCG-ALL-2015 HR protocol. In March 2021, he developed isolated bone marrow relapse (morphological blasts 56%; MRD 50%) with negative CSF. Sequential CD19/CD22 CAR T therapy induced sustained remission. At the last follow-up (52 months post-CAR T), MRD remained below detection. Conclusions CNS-predominant B-ALL may present with recurrent seizures despite normal peripheral blood. Repeated CSF analysis and flow cytometry are essential when cytomorphology is negative. Sequential CD19/CD22 CAR T achieved durable remission in relapsed B-ALL with prior CNS involvement.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →